NO20052979L - Propargyl-trifluormetoksy-amino-benzotiazolderivater. - Google Patents
Propargyl-trifluormetoksy-amino-benzotiazolderivater.Info
- Publication number
- NO20052979L NO20052979L NO20052979A NO20052979A NO20052979L NO 20052979 L NO20052979 L NO 20052979L NO 20052979 A NO20052979 A NO 20052979A NO 20052979 A NO20052979 A NO 20052979A NO 20052979 L NO20052979 L NO 20052979L
- Authority
- NO
- Norway
- Prior art keywords
- present
- alkyl
- integer
- propargyl
- benzothiazole
- Prior art date
Links
- YFYWJBQXRSDKNU-UHFFFAOYSA-N 5-prop-2-ynyl-4-(trifluoromethoxy)-1,3-benzothiazol-2-amine Chemical compound C#CCC1=CC=C2SC(N)=NC2=C1OC(F)(F)F YFYWJBQXRSDKNU-UHFFFAOYSA-N 0.000 title 1
- 229910052799 carbon Inorganic materials 0.000 abstract 4
- 125000006728 (C1-C6) alkynyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
hvori Ri er til stede eller fraværende, og når tilstede er H, C1-C6 alkyl, C1-C6 alkynyl, -(CH2)yS(CH2)xCH3, Ci-C6 aminoalkyl, Ci-C6 hydroksyalkyl eller -CCH2)nC(=O) (C6H4) (CH2)R2; R2 er H eller C1-C4 alkyl; R3 er H eller C1-C4 alkyl; R4 er til stede eller fraværende, og når tilstede er H, C1-C6 alkyl, C1-C6 alkynyl, -(CH2)yS(CH2)xCH3, Ci-C6 aminoalkyl, d-C6 hydroksyalkyl eller -(CH2)nC(=O)(C6H4)(CH2)R2; hvori n er et heltall på fra 1 -6; hvori x er 0 er et heltall på fra 1 -5 og y er et heltall på 1-5, slik at x+y<6; minst en av Ri eller R4 er til stede; den stiplede linjen representerer en binding mellom et av nitrogenatomene og det intervenerende karbonatomet; og en hvilken som helst forbindelse er ladet når både Ri og R4 er til stede, eller en hvilken som helst spesifikk enantiomer derav eller et hvilket som helst farmasøytisk akseptabelt salt derav, og en fremgangsmåte for behandling av en neurologisk forstyrrelse eller multiple sklerose ved administrasjon av en terapeutisk effektiv mengde av en hvilken som helst av forbindelsene.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30154002A | 2002-11-21 | 2002-11-21 | |
| PCT/US2003/037592 WO2004047756A2 (en) | 2002-11-21 | 2003-11-20 | Propargyl-trifluoromethoxy-amino-benzothiazole derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052979D0 NO20052979D0 (no) | 2005-06-17 |
| NO20052979L true NO20052979L (no) | 2005-08-19 |
Family
ID=32392394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052979A NO20052979L (no) | 2002-11-21 | 2005-06-17 | Propargyl-trifluormetoksy-amino-benzotiazolderivater. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1569641A2 (no) |
| JP (1) | JP2006507350A (no) |
| KR (1) | KR20050083951A (no) |
| CN (1) | CN1741802A (no) |
| AU (1) | AU2003295898A1 (no) |
| BR (1) | BR0315704A (no) |
| CA (1) | CA2507414A1 (no) |
| IS (1) | IS7906A (no) |
| MX (1) | MXPA05005414A (no) |
| NO (1) | NO20052979L (no) |
| RU (1) | RU2005119307A (no) |
| WO (1) | WO2004047756A2 (no) |
| ZA (1) | ZA200504988B (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8759382B2 (en) | 2010-09-29 | 2014-06-24 | Teva Pharmaceutical Industries Ltd. | Propargyl-trifluoromethoxy-aminobenzothiazole derivatives, their preparation and use |
| CN103340859A (zh) * | 2013-06-04 | 2013-10-09 | 中国科学院昆明动物研究所 | 侧脑室mpp+给药建立非人灵长类帕金森病动物模型的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59112978A (ja) * | 1982-12-21 | 1984-06-29 | Shionogi & Co Ltd | プロピニルアミノチアゾ−ル誘導体 |
-
2003
- 2003-11-20 KR KR1020057009216A patent/KR20050083951A/ko not_active Withdrawn
- 2003-11-20 CN CNA2003801090823A patent/CN1741802A/zh active Pending
- 2003-11-20 BR BR0315704-0A patent/BR0315704A/pt not_active Application Discontinuation
- 2003-11-20 ZA ZA200504988A patent/ZA200504988B/en unknown
- 2003-11-20 CA CA002507414A patent/CA2507414A1/en not_active Abandoned
- 2003-11-20 EP EP03787112A patent/EP1569641A2/en not_active Withdrawn
- 2003-11-20 AU AU2003295898A patent/AU2003295898A1/en not_active Abandoned
- 2003-11-20 WO PCT/US2003/037592 patent/WO2004047756A2/en not_active Ceased
- 2003-11-20 RU RU2005119307/04A patent/RU2005119307A/ru not_active Application Discontinuation
- 2003-11-20 JP JP2004555702A patent/JP2006507350A/ja active Pending
- 2003-11-20 MX MXPA05005414A patent/MXPA05005414A/es not_active Application Discontinuation
-
2005
- 2005-06-17 NO NO20052979A patent/NO20052979L/no not_active Application Discontinuation
- 2005-06-22 IS IS7906A patent/IS7906A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004047756A3 (en) | 2004-07-08 |
| IS7906A (is) | 2005-06-22 |
| NO20052979D0 (no) | 2005-06-17 |
| JP2006507350A (ja) | 2006-03-02 |
| KR20050083951A (ko) | 2005-08-26 |
| WO2004047756A2 (en) | 2004-06-10 |
| MXPA05005414A (es) | 2006-05-25 |
| AU2003295898A1 (en) | 2004-06-18 |
| EP1569641A2 (en) | 2005-09-07 |
| BR0315704A (pt) | 2005-09-06 |
| CA2507414A1 (en) | 2004-06-10 |
| CN1741802A (zh) | 2006-03-01 |
| ZA200504988B (en) | 2006-08-30 |
| RU2005119307A (ru) | 2006-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU1199A (sh) | Derivati benzosulfona | |
| HUP0002495A1 (hu) | VLA-4 Által közvetített leukocita adhéziót gátló dipeptidszármazékok és rokon vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| DE69931393D1 (de) | Antithrombotische amide | |
| HUP0400365A2 (hu) | 3-Fluor-pirrolidinek, mint cukorbetegség elleni szerek és a vegyületeket tartalmazó gyógyszerkészítmények | |
| MXPA03001072A (es) | El uso de bencilidenaminoguanidinas e hidroxiguanidinas como ligandos de receptor de melanocortina. | |
| HUP9900851A2 (hu) | Benzotiofénszármazékok felhasználása véredény simaizom sejtek migrálásának inhibiálására alkalmas gyógyszerkészítmények előállítására | |
| TW200420542A (en) | A compound having TGF β inhibition activity and a medicinal composition containing the same | |
| ES2149350T3 (es) | Compuestos y liposomas farmaceuticamente activos y metodos para su utilizacion. | |
| MXPA04002167A (es) | Inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes. | |
| HUP0303756A2 (hu) | 1-Aril- vagy 1-alkilszulfonil-heterociklobenzazolok és eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények | |
| MXPA03011244A (es) | Nuevos derivados de indol con afinidad por el receptor 5-ht6. | |
| MA26861A1 (fr) | Inhibiteurs non peptidiques de la liaison cellulaire sous la dependance de vla-4 utiles dans le traitement des maladies inflammatoires, auto-immunes et respiratoires | |
| HUP0302475A2 (hu) | Eljárás allergia kezelésére szubsztituált pirazolok alkalmazásával | |
| AU2330202A (en) | Treatment of statin side effects | |
| MY140525A (en) | Pharmaceutical uses for alpha2delta ligands | |
| TW427887B (en) | Pharmaceutical composition comprising a benzimidazole derivative for treating viral infections | |
| MXPA02001571A (es) | Metodo de tratamiento para el cancer. | |
| HUP9801946A2 (hu) | 5-HT-felvétel-inhibitorból és szelektív 5-H1A-antagonistából álló kombinációs gyógyászati készítmény és eljárás előállítására | |
| AU2003274946A1 (en) | Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein | |
| HU9502456D0 (en) | Polyamine derivatives as radioprotective agents | |
| MXPA03000547A (es) | Uso de derivados de amidas de acido valproico y de acido 2-valproenico, para el tratamiento de manias en trastornos bipolares. | |
| MA27257A1 (fr) | Composes utiles pour le traitement du charbon et l'inhibition du gene letal | |
| HUP9901212A2 (hu) | N,N-dialkil-N-[2-(3-alkoxi-fenoxi)-etil]-amin-származékok, az ezeket tartalmazó gyógyszerkészítmények és helyi érzéstelenítőkként való alkalmazásuk | |
| HUP9901093A2 (hu) | Eljárás benzotiofénszármazékok felhasználása melanóma gátlására alkalmas gyógyszerkészítmények előállítására | |
| NO20023041L (no) | Fremgangsmåte for fremstilling av pyrazolopyridazinderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |